Lv11
18 积分 2026-01-09 加入
Real-life intraclass switch among IL-17 inhibitors in psoriasis: results from a single-centre, 24-week, retrospective study
2小时前
已完结
A map of molecular drug targets and therapeutics for the US FDA-approved drugs: The impact of expedited regulatory pathways and first-in-class drug approvals on drug innovation
4天前
已完结
Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study
5天前
已完结
Durability and long-term outcomes of biologic therapies in psoriasis
5天前
已关闭
Association of healthy lifestyle behaviours with incident irritable bowel syndrome: a large population-based prospective cohort study
7天前
已完结
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase
11天前
已完结
IFN-γ/IL-6 and related cytokines in chronic spontaneous urticaria: evaluation of their pathogenetic role and changes during omalizumab therapy
11天前
已完结
Chronic Spontaneous Urticaria
11天前
已关闭
Insights into omalizumab use in Auckland City Hospital's immunology 2023 chronic spontaneous urticaria cohort
11天前
已关闭
Chronic Spontaneous Urticaria in Belgium: Deciphering the Clinical Profile and Treatment of Patients Visiting an Urban City Immunology Departmen
11天前
已关闭
皖公网安备34019202002308
